CAS: 1004990-28-6 - PF-AKT400
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | PF-AKT400 REF: TM-T5508CAS: 1004990-28-6 | 98.21% | 93,00 €~1.068,00 € | Fr 13 Dez 24 |
 | (S)-N-[[3-Amino-1-(5-ethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrrolidin-3-yl]methyl]-2,4-difluorobenzamide REF: 3D-FA102747CAS: 1004990-28-6 | Min. 95% | Nachfragen | Fr 17 Jan 25 |
PF-AKT400
CAS:1004990-28-6
PF-AKT400 (AKT protein kinase inhibitor) is a broadly selective and ATP-competitive inhibitor of Akt.
Formel:
C20H22F2N6O
Reinheit:
98.21%
Farbe und Form:
Solid
Molekulargewicht:
400.43
Ref: TM-T5508
| 1mg | 93,00 € | ||
| 5mg | 222,00 € | ||
| 10mg | 319,00 € | ||
| 25mg | 540,00 € | ||
| 50mg | 770,00 € | ||
| 100mg | 1.068,00 € | ||
| 1mL*10mM (DMSO) | 249,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 13. Dezember 2024
![(S)-N-[[3-Amino-1-(5-ethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrrolidin-3-yl]methyl]-2,4-difluoroben…](https://static.cymitquimica.com/products/3D/thumb/FA102747.jpg)
(S)-N-[[3-Amino-1-(5-ethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrrolidin-3-yl]methyl]-2,4-difluorobenzamide
CAS:1004990-28-6
(S)-N-[[3-Amino-1-(5-ethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrrolidin-3-yl]methyl]-2,4-difluorobenzamide is a prodrug that is converted to the active form by esterases in the …
Formel:
C20H22F2N6O
Reinheit:
Min. 95%
Molekulargewicht:
400.43 g/mol
Ref: 3D-FA102747
| 1mg | Nachfragen | ||
| 5mg | Nachfragen | ||
| 10mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 17. Januar 2025
